Clinical management of skin and soft tissue infections in the U.S. Emergency departments

Western Journal of Emergency Medicine

Volumn 15, Issue 4, 2014, Pages 491-498

  Mistry, Rakesh D ^a   Shapiro, Daniel J ^b   Goyal, Monika K ^c   Zaoutis, Theoklis E ^d   Gerber, Jeffrey S ^d   Liu, Catherine ^e   Hersh, Adam L ^f  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Emergency department; Epidemiology; Skin infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; DAPTOMYCIN; LINEZOLID; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADJUVANT THERAPY; ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CELL COUNT; BLOOD CULTURE; CROSS-SECTIONAL STUDY; EMERGENCY WARD; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITALIZATION; HUMAN; INCISION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL DRAINAGE; CLINICAL PRACTICE; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY HEALTH SERVICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PHYSICIAN'S PRACTICE PATTERNS; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; UNITED STATES;

EID: 84918555447     PISSN: 1936900X     EISSN: 19369018     Source Type: Journal    
DOI: 10.5811/westjem.2014.4.20583     Document Type: Article

References (37)

1. Rajendran PM, Young D, Maurer T, et al. randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007;51(11):4044-4048.
2. Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. 2005;45(3):311-320.
3. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(14):1436-1444.
4. Ruhe JJ, Smith N, Bradsher RW, et al. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis. 2007;44(6):777-784.
5. Miller LG, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis. 2007;44(4):483-492.
6. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40(12):1785-1791.
7. Moran GJ, Amii RN, Abrahamian FM,et al. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis. 2005;11(6):928-930.
8. Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51(3):291-298.
9. Hersh AL, Chambers HF, Maselli JH, et al. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168(14):1585-1591.
10. Elliott DJ, Zaoutis TE, Troxel AB, et al. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Pediatrics. 2009;123(6):e959-966.
11. Ramirez-Schrempp D, Dorfman DH, Baker WE, et al. Ultrasound soft-tissue applications in the pediatric emergency department: to drain or not to drain? Pediatr Emerg Care. 2009;25(1):44-48.
12. Tayal VS, Hasan N, Norton HJ,et al. The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department. Acad Emerg Med. 2006;13(4):384-388.
13. Iverson K, Haritos D, Thomas R, et al. The effect of bedside ultrasound on diagnosis and management of soft tissue infections in a pediatric ED. Am J Emerg Med. 2012;30(8):1347-1351.
14. Mistry RD, Weisz K, Scott HF,et al. Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era. Acad Emerg Med. 2010;17(2):187-193.
15. Baumann BM, Russo CJ, Pavlik D, et al. Management of pediatric skin abscesses in pediatric, general academic and community emergency departments. West J Emerg Med. 2011;12(2):159-167.
16. Gorwitz RJ, Jernigan DB, Powers JH, et al. Strategies for Clinical Management of MRSA in the Community: Summary of an Experts' Meeting Convened by the Centers for Disease Control and Prevention. 2006. Available at: http://www.cdc.gov/ncidod/dhqp/ar-mrsa-ca.html.
17. Chen AE, Carroll KC, Diener-West M, et al. Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics. 2011;127(3):e573-580.
18. Schmitz GR, Bruner D, Pitotti R, et al. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med. 56(3):283-287.
19. Duong M, Markwell S, Peter J,et al. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010;55(5):401-407.
20. Rajendran PM, Young DM, Maurer T, et al. Antibiotic use in the treatment of soft tissue abscesses: a survey of current practice. Surg Infect (Larchmt). 2007;8(2):237-238.
21. NAMCS/NHAMCS - About the Ambulatory Health Care Surveys. Available at: http://www.cdc.gov/nchs/ahcd/about-ahcd.htm. Accessed November 25, 2013.
22. Qualls ML, Mooney MM, Camargo CA Jr, et al. Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 1997-2007. Clin Infect Dis. 2012;55(1):103-105.
23. Llera JL, Levy RC. Treatment of cutaneous abscess: a double-blind clinical study. Ann Emerg Med. 1985;14(1):15-19.
24. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285-292.
25. Levy JA, Noble VE. Bedside ultrasound in pediatric emergency medicine. Pediatrics. 2008;121(5):e1404-1412.
26. Vieira RL, Bachur R. Bedside ultrasound in pediatric practice. Pediatrics. 2014;133(1):1-3.
27. Squire BT, Fox JC, Anderson C. ABSCESS: applied bedside sonography for convenient evaluation of superficial soft tissue infections. Acad Emerg Med. 2005;12(7):601-606.
28. Fritz SA, Garbutt J, Elward A, et al. Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics. 2008;121(6):1090-1098.
29. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674.
30. Hota B, Ellenbogen C, Hayden MK, et al. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med. 2007;167(10):1026-1033.
31. Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. Population: a retrospective population-based study. BMC Infect Dis. 2013;13(1):252.
32. Mistry RD, Scott HF, Zaoutis TE, et al. Emergency Department Treatment Failures for Skin Infections in the Era of Community-Acquired Methicillin-Resistant Staphylococcus aureus. Pediatr Emerg Care. 2011;27(1):21-26.
33. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23(2):123-127.
34. Jeng A, Beheshti M, Li J, et al. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore). 2010;89(4):217-226.
35. Talan DA, Krishnadasan A, Gorwitz RJ, et al. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis. 2011;53(2):144-149.
36. Hook EW 3rd, Hooton TM, Horton CA, et al. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146(2):295-297.
37. Cooper RJ. NHAMCS: does it hold up to scrutiny? Ann Emerg Med. 2012;60(6):722-725.